Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Prostatic Neoplasms 28Neoplasm Metastasis 6Recurrence 5Breast Neoplasms 4Stomach Neoplasms 3Prostate Cancer Metastatic 3Neoplastic Cells, Circulating 3Carcinoma, Transitional Cell 3Carcinoma, Non-Small-Cell Lung 3Ovarian Neoplasms 2Brain Neoplasms 2Urinary Bladder Neoplasms 1Testicular Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Prostatic Neoplasms, Castration-Resistant 1Prostate Cancer, Hereditary, 7 1Penile Neoplasms 1Nonseminomatous germ cell tumor 1Metastatic Castration-resistant Prostate Cancer, MCRPC 1Metastatic Castration-resistant Prostate Cancer 1Metastatic Breast Cancer With Intracranial Metastases 1Lung Neoplasms 1Liposarcoma 1Hormone-Resistant Prostate Cancer 1Hormone Refractory Prostate Cancer 1Head and Neck Neoplasms 1Glioblastoma 1Esophageal Neoplasms 1Diarrhea 1

Interventions

Cisplatin 39Radiotherapy 21Carboplatin 21Cetuximab 20Paclitaxel 19Docetaxel 17Radiotherapy, Intensity-Modulated 15pembrolizumab 14Fluorouracil 13Drug Therapy 10Nivolumab 8Radiation 6cemiplimab 5atezolizumab 5Panitumumab 5Oxaliplatin 5Erlotinib Hydrochloride 5Chemoradiotherapy 5Afatinib 5Surgical Procedures, Operative 4durvalumab 3Surveys and Questionnaires 3Methotrexate 3Leucovorin 3Lapatinib 3130-nm albumin-bound paclitaxel 3toripalimab 2palbociclib 2osimertinib 2dacomitinib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Carcinoma, Squamous Cell × cabazitaxel × Clear all
NCT01528163 2017-06-14

RACATREX

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Phase 2 Completed
101 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡